| Dr Michael Wayne Johnson, DC | |
|
7100 E 151st St S, Bixby, OK 74008-4137 | |
| (918) 691-7275 | |
| (918) 366-4460 |
| Full Name | Dr Michael Wayne Johnson |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 12 Years |
| Location | 7100 E 151st St S, Bixby, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306183868 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 4096 (Oklahoma) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Brian S. Hicks D.c. Inc Pc | 0042388837 | 3 |
News Archive
New findings from a research study led by physicians at Scripps Health reveal that the investigational drug cangrelor has the unique properties of achieving very fast blood thinning effects when needed to protect from heart attacks, but also dissipates rapidly so patients can undergo surgery without the excessive bleeding often associated with blood thinning medications.
Sanofi-aventis U.S. announced today that it has acquired from biotechnology company Antisoma plc the U.S. commercial rights to Oforta (fludarabine phosphate film-coated tablets), an oral B-cell chronic lymphocytic leukemia (CLL) drug. Oforta is currently approved in the United States for use as a second-line therapy to treat adults with B-cell CLL.
Aeterna Zentaris Inc. today announced that the United States Patent and Trademark Office has granted a patent for the use of its oral ghrelin agonist, AEZS-130 (EP1572) as a diagnostic test for adult growth hormone deficiency.
Urologists at a leading Irish hospital have reported an alarming increase in the number of teenage boys and young men developing mumps orchitis, in a paper published in the April issue of the urology journal BJUI.
› Verified 7 days ago
| Provider Name | Brian S. Hicks D.c. Inc Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1265601900 PECOS PAC ID: 0042388837 Enrollment ID: O20081007000271 |
News Archive
New findings from a research study led by physicians at Scripps Health reveal that the investigational drug cangrelor has the unique properties of achieving very fast blood thinning effects when needed to protect from heart attacks, but also dissipates rapidly so patients can undergo surgery without the excessive bleeding often associated with blood thinning medications.
Sanofi-aventis U.S. announced today that it has acquired from biotechnology company Antisoma plc the U.S. commercial rights to Oforta (fludarabine phosphate film-coated tablets), an oral B-cell chronic lymphocytic leukemia (CLL) drug. Oforta is currently approved in the United States for use as a second-line therapy to treat adults with B-cell CLL.
Aeterna Zentaris Inc. today announced that the United States Patent and Trademark Office has granted a patent for the use of its oral ghrelin agonist, AEZS-130 (EP1572) as a diagnostic test for adult growth hormone deficiency.
Urologists at a leading Irish hospital have reported an alarming increase in the number of teenage boys and young men developing mumps orchitis, in a paper published in the April issue of the urology journal BJUI.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Wayne Johnson, DC 7100 E 151st St S, Bixby, OK 74008-4137 Ph: (918) 691-7275 | Dr Michael Wayne Johnson, DC 7100 E 151st St S, Bixby, OK 74008-4137 Ph: (918) 691-7275 |
News Archive
New findings from a research study led by physicians at Scripps Health reveal that the investigational drug cangrelor has the unique properties of achieving very fast blood thinning effects when needed to protect from heart attacks, but also dissipates rapidly so patients can undergo surgery without the excessive bleeding often associated with blood thinning medications.
Sanofi-aventis U.S. announced today that it has acquired from biotechnology company Antisoma plc the U.S. commercial rights to Oforta (fludarabine phosphate film-coated tablets), an oral B-cell chronic lymphocytic leukemia (CLL) drug. Oforta is currently approved in the United States for use as a second-line therapy to treat adults with B-cell CLL.
Aeterna Zentaris Inc. today announced that the United States Patent and Trademark Office has granted a patent for the use of its oral ghrelin agonist, AEZS-130 (EP1572) as a diagnostic test for adult growth hormone deficiency.
Urologists at a leading Irish hospital have reported an alarming increase in the number of teenage boys and young men developing mumps orchitis, in a paper published in the April issue of the urology journal BJUI.
› Verified 7 days ago
Dr. Kasey Michelle Nichols, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 7100 E 151st St S, Bixby, OK 74008 Phone: 918-366-4461 Fax: 918-366-4460 | |
Brian Scott Hicks, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 7100 E 151st St S, Bixby, OK 74008 Phone: 918-366-4461 Fax: 918-366-4460 | |
Dr. Eric Walsh Lehrman, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 12345 S Memorial Dr Ste 111, Bixby, OK 74008 Phone: 918-394-9400 | |
Bixby Chiropractic Clinic Chiropractor Medicare: Medicare Enrolled Practice Location: 7100 E 151st St S, Bixby, OK 74008 Phone: 918-366-4461 Fax: 918-366-4460 | |
Dr. Evlyn Kathryn Smith, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 5085 E 151st St S Ste B, Bixby, OK 74008 Phone: 918-366-7100 | |
Body Worx Chiropractic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 5085 East 151st St., Suite B, Bixby, OK 74008 Phone: 918-366-7100 Fax: 918-366-7101 |